share_log

HC Wainwright & Co. Upgrades Context Therapeutics to Buy, Announces $5 Price Target

HC Wainwright & Co. Upgrades Context Therapeutics to Buy, Announces $5 Price Target

HC Wainwright & Co.將Context Therapeutics升級爲收購,宣佈5美元的目標
Benzinga ·  2023/11/01 07:17

HC Wainwright & Co. analyst Emily Bodnar upgrades Context Therapeutics (NASDAQ:CNTX) from Neutral to Buy and announces $5 price target.

HC Wainwright & Co.分析師Emily Bodnar 將Context Therapeutics(納斯達克股票代碼:CNTX)從中性上調至買入,並宣佈5美元的目標價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論